Akèy › Kansè pwostat › South Carolina
Etid klinik pou Kansè pwostat nan South Carolina
42 etid pou Kansè pwostat ap chèche patisipan nan sit nan South Carolina.
Vil nan South Carolina
Tèks ofisyèl etid la (Anglè)
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
- Saint Francis Hospital, Greenville
- Saint Francis Cancer Center, Greenville
- Self Regional Healthcare, Greenwood
Ap rekriteFaz 3
Laj 18 ak plis · Gason · Mizajou Oct 2, 2026 · NCT06931340Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- AnMed Health Cancer Center, Anderson
- Prisma Health Richland Hospital, Columbia
- McLeod Regional Medical Center, Florence
- ak 12 plis
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 40 a 75 · Tout sèks · Mizajou Oct 2, 2026 · NCT05334069Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
- Gibbs Cancer Center-Gaffney, Gaffney
- Gibbs Cancer Center-Pelham, Greer
- Spartanburg Medical Center, Spartanburg
- ak 1 plis
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT06632977Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- Medical University of South Carolina, Charleston
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT03866382Prostate Cancer Risk Identification in a Multi-Ethnic Cohort: a Prospective US-based Multi-center Validation Study of Proclarix
- Carolina Urologic Research Center, Myrtle Beach
Ap rekriteEtid obsèvasyon
Laj 40 a 75 · Gason · Mizajou Sep 28, 2026 · NCT07543757Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer
- Research Site, Myrtle Beach
Ap rekriteFaz 1/2
Laj 18 a 130 · Gason · Mizajou Sep 25, 2026 · NCT07181161Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer
- Carolina Urologic Research Center, Myrtle Beach
Ap rekriteFaz 1/2
Laj 18 ak plis · Gason · Mizajou Sep 25, 2026 · NCT06800313Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer
- Carolina Urologic Research Center, Myrtle Beach
Ap rekriteFaz 1
Laj 18 ak plis · Gason · Mizajou Sep 25, 2026 · NCT06801236A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
- Ralph H. Johnson VA Health Care System (RHJVAHCS)-Urology ( Site 0083), Charleston
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT06136650This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
- Grand Strand Medical Center, Myrtle Beach
- Carolina Urologic Research Center, LLC, Myrtle Beach
- Parkway Surgery Center, Myrtle Beach
Ap rekriteFaz 3
Laj 18 ak plis · Gason · Mizajou Sep 24, 2026 · NCT07028853A Study in Patients With Metastatic Castration-Resistant Prostate Cancer
- START Carolinas, Myrtle Beach
Ap rekriteFaz 1
Laj 18 ak plis · Gason · Mizajou Sep 24, 2026 · NCT07719361Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
- Carolina Urologic Research Center, Myrtle Beach
Ap rekriteFaz 2/3
Laj 18 a 100 · Gason · Mizajou Sep 22, 2026 · NCT06780670A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
- South Texas Accelerated Research Therapeutics - Carolinas, Myrtle Beach
Ap rekriteFaz 3
Laj 18 ak plis · Gason · Mizajou Sep 22, 2026 · NCT07213674Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
- MUSC Hollings Cancer Center, Charleston
- Carolina Urologic Research Center, Myrtle Beach
Ap rekriteFaz 3
Laj 18 a 100 · Gason · Mizajou Sep 22, 2026 · NCT06855277A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
- Research Site, Myrtle Beach
Ap rekriteFaz 3
Laj 18 ak plis · Gason · Mizajou Sep 18, 2026 · NCT06952803High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers
- Ralph H. Johnson VA Medical Center, Charleston, SC, Charleston
Ap rekriteFaz 2
Laj 18 ak plis · Gason · Mizajou Sep 17, 2026 · NCT05011383A Biomarker Study in Men With Localized Prostate Cancer Treated With Aglatimagene Besadenovec
- START Carolinas, Myrtle Beach
Ap rekriteFaz 2
Laj 18 ak plis · Gason · Mizajou Sep 15, 2026 · NCT07332000Sacral Neuromodulation for Male Overactive Bladder (MOAB)
- Lowcountry Urology Clinics, North Charleston
Ap rekrite
Laj 18 ak plis · Gason · Mizajou Sep 14, 2026 · NCT06511141Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
- Carolina Urologic Research Center, Myrtle Beach
Ap rekriteFaz 3
Laj 18 ak plis · Gason · Mizajou Sep 11, 2026 · NCT06056830Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
- McLeod Regional Medical Center, Florence
- Gibbs Cancer Center-Gaffney, Gaffney
- Self Regional Healthcare, Greenwood
- ak 3 plis
Ap rekriteFaz 3
Laj 18 ak plis · Gason · Mizajou Sep 10, 2026 · NCT05946213Study of JANX014 in Subjects With Metastatic Castration-Resistant Prostate Cancer
- Medical University of South Carolina - Hollings Cancer Center, Charleston
- Prisma Health Cancer Institute, Greenville
Ap rekriteFaz 1
Laj 18 ak plis · Gason · Mizajou Sep 3, 2026 · NCT07545811A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer
- Carolina Urologic Research Center, Myrtle Beach
Ap rekriteFaz 2
Laj 18 ak plis · Gason · Mizajou Sep 3, 2026 · NCT07005154AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
- Research Site, Myrtle Beach
Ap rekriteFaz 3
Laj 18 ak plis · Gason · Mizajou Aug 26, 2026 · NCT07611110A Single-Arm Phase II Study of Neoadjuvant Intensified Androgen Deprivation (Leuprolide and Abiraterone Acetate) in Combination With AKT Inhibition (Capivasertib) for High-Risk Localized Prostate Cancer With PTEN Loss
- Ralph H. Johnson VA Medical Center, Charleston, SC, Charleston
Ap rekriteFaz 2
Laj 18 ak plis · Gason · Mizajou Aug 25, 2026 · NCT05593497Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
- Medical University of South Carolina, Charleston
Ap rekriteFaz 3
Laj 18 ak plis · Gason · Mizajou Aug 19, 2026 · NCT04423211A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
- Carolina Urologic Research Center, Myrtle Beach
Ap rekriteFaz 2
Laj 18 ak plis · Gason · Mizajou Aug 17, 2026 · NCT06842498Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
- Medical University of South Carolina, Charleston
Ap rekriteFaz 1
Laj 18 a 100 · Gason · Mizajou Aug 13, 2026 · NCT05519449Evaluation of Neoadjuvant Xaluritamig in Localized Prostate Cancer
- Carolina Urologic Research Center, Myrtle Beach
Ap rekriteFaz 1
Laj 18 ak plis · Gason · Mizajou Jul 31, 2026 · NCT06613100PSMA PET Combined With MRI for the Detection of PCa
- Atlantic Urology Specialists, Myrtle Beach
Ap rekriteFaz 3Volontè an sante akeyi
Laj 18 ak plis · Gason · Mizajou Jul 23, 2026 · NCT07052214Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
- Medical University of South Carolina, Charleston
- Levine Cancer Institute-Rock Hill, Rock Hill
Ap rekriteFaz 3
Laj 18 ak plis · Gason · Mizajou Jul 14, 2026 · NCT06592924A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
- Carolina Urologic Research Center, the START Center for Cancer Research, Myrtle Beach
Ap rekriteFaz 1
Laj 18 ak plis · Gason · Mizajou Jul 9, 2026 · NCT07103018Study Evaluating the Safety, Tolerability, and Efficacy of Xaluritamig in Combination With Androgen Receptor Pathway Inhibitors in Participants With Metastatic Hormone-sensitive Prostate Cancer
- South Texas Accelerated Research Therapeutics - Carolinas, Myrtle Beach
Ap rekriteFaz 1
Laj 18 ak plis · Gason · Mizajou Jul 2, 2026 · NCT07140900International Registry for Men With Advanced Prostate Cancer (IRONMAN)
- Ralph H. Johnson VA Medical Center, Charleston
Ap rekriteEtid obsèvasyon
Laj 21 ak plis · Gason · Mizajou May 22, 2026 · NCT03151629T-reg Function Changes: a Novel Immune Regulatory Effect Underlying Benefit of Statin Use on Lethal Prostate Cancer
- Hollings Cancer Center at Medical University of South Carolina, Charleston
Ap rekriteFaz 2
Laj 18 ak plis · Gason · Mizajou Mar 4, 2026 · NCT05586360Hypofractionated Radiotherapy With a Focal Microboost for High-Risk and Locally Advanced Prostate Cancer
- Medical University of South Carolina Hollings Cancer Center, Charleston
Ap rekriteFaz 2
Laj 18 ak plis · Gason · Mizajou Feb 5, 2026 · NCT07325721A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer
- Carolina Urologic Research Center, Myrtle Beach
Ap rekriteFaz 1
Laj 18 ak plis · Gason · Mizajou Feb 4, 2026 · NCT04729114cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
- Medical University of South Carolina, Charleston
- McLeod Health, Florence
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 40 ak plis · Tout sèks · Mizajou Jan 20, 2026 · NCT05366881Vitamin D for Prostate Endocrine Therapy
- Gibbs Cancer Center-Gaffney, Gaffney
- Saint Francis Hospital, Greenville
- Saint Francis Cancer Center, Greenville
- ak 3 plis
Ap rekriteFaz 3
Laj 50 ak plis · Gason · Mizajou Jan 15, 2026 · NCT05838716A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
- Research Site 123, Charleston
- Research Site 108, Greenville
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Nov 21, 2025 · NCT05914116SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Greenville
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Oct 28, 2025 · NCT03452774Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.